The Pharmacokinetics of a Hemp-Based Topical Product

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
Johns Hopkins University
Study ID
NCT07603518
Phase
PHASE1
Status
Recruiting
Apply to this trial

Conditions

  • Cannabis

Eligibility Criteria

Sex
ALL
Age
18 Years - 55 Years
Healthy Volunteers
Accepted

Interventions

  • CBD — DRUG
    CBD will be topically applied
  • THC — DRUG
    THC will be topically applied

Study Details

This study will evaluate the pharmacokinetic effects of acute and chronic dosing of a hemp-based cannabidiol (CBD) topical lotion with low levels of delta-9-tetrahydrocannabinol (THC) in a sanitized and controlled environment.

Key Dates

First listed
May 22, 2026
Start date
May 26, 2026
Status verified
Aug 2026
Primary completion
Sep 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE

Arms

  • Experimental: Topical CBD Product with low level of THC
    Participants will topically apply a high CBD-product that also contains low levels of THC.

Primary Outcome Measure

Change in concentration of oral fluid cannabinoids [ Time Frame: Days 1-7 and Day 14 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Behavioral Pharmacology Research UnitBaltimoreMaryland21224
Tory Spindle, Ph.D. (PRINCIPAL_INVESTIGATOR)

Find similar trials in Baltimore, MD

By research site
Behavioral Pharmacology Research Unit· Baltimore, MD

Related Studies